• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

希腊中部 Toll 样受体 2、4 和 9 多态性及其与 ICU 获得性感染的关系。

Toll-like receptor 2, 4 and 9 polymorphisms and their association with ICU-acquired infections in Central Greece.

机构信息

Department of Critical Care, University Hospital of Larissa, Greece; School of Medicine, University of Thessaly, Thessaly, Greece.

Cytogenetics and Molecular Genetics Department, School of Medicine, University of Thessaly, Thessaly, Greece.

出版信息

J Crit Care. 2018 Oct;47:1-8. doi: 10.1016/j.jcrc.2018.05.012. Epub 2018 May 25.

DOI:10.1016/j.jcrc.2018.05.012
PMID:29860039
Abstract

PURPOSE

To test the potential of four common Toll-like receptor (TLR) polymorphisms to predispose to specific intensive care unit (ICU)-acquired infections and affect outcomes in a Greek ICU.

MATERIALS AND METHODS

The incidence of TLR2-Arg753Gln, TLR4-Asp299Gly, TLR4-Thr399Ile and TLR9-T1237C polymorphisms, and their association with ICU-acquired infections and patients' clinical outcomes were prospectively evaluated The examined genetic polymorphisms were assessed by real-time Polymerase-Chain-Reaction (PCR).

RESULTS

During a 15-month period, 224 patients were enrolled and genotyped. The prevalence of genetic polymorphisms for TLR4-Asp299Gly, TLR4-Thr399Ile, mixed TLR4-Asp299Gly/Thr399Ile, TLR9-T1237C and TLR2-Arg753Gln was 14.4%, 14.7%, 11.2%, 24.5% and 2.2%, respectively. TLR4 polymorphisms were associated with increased susceptibility towards specific ICU-acquired infections, i.e. Gram-negative central-nervous-system infections (CNSI), ventilator-associated pneumonia (VAP) and urinary-tract infections (UTI), principally due to multi-drug resistant (MDR) Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumonia, respectively (all P < 0.05). TLR9-T1237C polymorphism was associated with lower incidence and fewer relapses of CNSIs and UTIs when compared to mixed TLR4-Asp299Gly/Thr399Ile polymorphism group (P ≤ 0.039). ICU-stay was significantly prolonged in TLR4 polymorphisms (P ≤ 0.0416).

CONCLUSIONS

Common TLR-signaling polymorphisms might be implicated in the clinical phenotype of ICU-acquired infections in Central Greece. The possible impact of TLR4 polymorphisms on enhanced susceptibility towards Gram-negative MDR-infections in defined critical-disease states warrants further investigation. Trial Registration Clinical Trials.gov identifier: NCT00932243.

摘要

目的

检测四种常见 Toll 样受体(TLR)多态性是否可能导致特定的重症监护病房(ICU)获得性感染,并影响希腊 ICU 患者的预后。

材料与方法

前瞻性评估 TLR2-Arg753Gln、TLR4-Asp299Gly、TLR4-Thr399Ile 和 TLR9-T1237C 多态性的发生率,及其与 ICU 获得性感染和患者临床结局的关系。通过实时聚合酶链反应(PCR)检测所研究的遗传多态性。

结果

在 15 个月的时间内,共纳入并对 224 例患者进行了基因分型。TLR4-Asp299Gly、TLR4-Thr399Ile、混合 TLR4-Asp299Gly/Thr399Ile、TLR9-T1237C 和 TLR2-Arg753Gln 遗传多态性的发生率分别为 14.4%、14.7%、11.2%、24.5%和 2.2%。TLR4 多态性与特定 ICU 获得性感染的易感性增加相关,主要是由于多重耐药(MDR)鲍曼不动杆菌、铜绿假单胞菌和肺炎克雷伯菌所致的革兰阴性中枢神经系统感染(CNSI)、呼吸机相关性肺炎(VAP)和尿路感染(UTI)(均 P<0.05)。与混合 TLR4-Asp299Gly/Thr399Ile 多态性组相比,TLR9-T1237C 多态性与 CNSI 和 UTI 的发生率较低和复发较少相关(均 P≤0.039)。TLR4 多态性患者 ICU 住院时间显著延长(P≤0.0416)。

结论

常见 TLR 信号转导多态性可能与希腊中部 ICU 获得性感染的临床表型有关。TLR4 多态性对特定危重病状态下革兰阴性 MDR 感染易感性增加的可能影响需要进一步研究。

临床试验注册号

NCT00932243。

相似文献

1
Toll-like receptor 2, 4 and 9 polymorphisms and their association with ICU-acquired infections in Central Greece.希腊中部 Toll 样受体 2、4 和 9 多态性及其与 ICU 获得性感染的关系。
J Crit Care. 2018 Oct;47:1-8. doi: 10.1016/j.jcrc.2018.05.012. Epub 2018 May 25.
2
Polymorphisms of the toll-like receptor 2 and 4 genes are associated with faster progression and a more severe course of sepsis in critically ill patients.Toll样受体2和4基因的多态性与重症患者脓毒症进展更快及病情更严重有关。
J Int Med Res. 2014 Feb;42(1):93-110. doi: 10.1177/0300060513504358. Epub 2013 Dec 23.
3
Clinical Implication of Toll-Like Receptors (TLR2 and TLR4) in Acute Myeloid Leukemia Patients.Toll 样受体(TLR2 和 TLR4)在急性髓系白血病患者中的临床意义。
Asian Pac J Cancer Prev. 2020 Nov 1;21(11):3177-3183. doi: 10.31557/APJCP.2020.21.11.3177.
4
Toll-like receptors TLR4 (Asp299Gly and Thr399Ile) and TLR2 (Arg677Trp and Arg753Gln) gene polymorphisms in end-stage renal disease patients on peritoneal dialysis.终末期肾病腹膜透析患者中Toll样受体TLR4(Asp299Gly和Thr399Ile)及TLR2(Arg677Trp和Arg753Gln)基因多态性
Int Urol Nephrol. 2015 Dec;47(12):2031-7. doi: 10.1007/s11255-015-1124-8. Epub 2015 Oct 22.
5
Variant Toll-like receptor4 (Asp299Gly and Thr399Ile alleles) and Toll-like receptor2 (Arg753Gln and Arg677Trp alleles) in colorectal cancer.结直肠癌中的 Toll 样受体 4 变体(Asp299Gly 和 Thr399Ile 等位基因)及 Toll 样受体 2(Arg753Gln 和 Arg677Trp 等位基因)
Iran J Allergy Asthma Immunol. 2011 Jun;10(2):91-9.
6
Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer.评估 Toll 样受体 (TLRs) 在结直肠癌患者癌症发展和进展中的检测。
PLoS One. 2018 Jun 8;13(6):e0197327. doi: 10.1371/journal.pone.0197327. eCollection 2018.
7
Analysis of TLR4 and TLR2 polymorphisms in inflammatory bowel disease in a Guangxi Zhuang population.广西壮族人群中 TLR4 和 TLR2 多态性与炎症性肠病的相关性分析。
World J Gastroenterol. 2012 Dec 14;18(46):6856-60. doi: 10.3748/wjg.v18.i46.6856.
8
Investigation of TLR2 and TLR4 Polymorphisms and Sepsis Susceptibility: Computational and Experimental Approaches.TLR2 和 TLR4 多态性与脓毒症易感性的研究:计算和实验方法。
Int J Mol Sci. 2022 Sep 19;23(18):10982. doi: 10.3390/ijms231810982.
9
TLR2 and TLR4 gene polymorphisms in Turkish vitiligo patients.土耳其白癜风患者 TLR2 和 TLR4 基因多态性。
J Eur Acad Dermatol Venereol. 2013 Jan;27(1):e85-90. doi: 10.1111/j.1468-3083.2012.04514.x. Epub 2012 Mar 16.
10
Association between TLR2 and TLR4 Gene Polymorphisms and the Susceptibility to Inflammatory Bowel Disease: A Meta-Analysis.Toll样受体2和Toll样受体4基因多态性与炎症性肠病易感性的关联:一项荟萃分析
PLoS One. 2015 May 29;10(5):e0126803. doi: 10.1371/journal.pone.0126803. eCollection 2015.

引用本文的文献

1
A chronic Acinetobacter baumannii pneumonia model to study long-term virulence factors, antibiotic treatments, and polymicrobial infections.一种用于研究长期毒力因子、抗生素治疗和混合感染的慢性鲍曼不动杆菌肺炎模型。
Nat Commun. 2025 Aug 15;16(1):7617. doi: 10.1038/s41467-025-62655-4.
2
A chronic murine model of pulmonary infection enabling the investigation of late virulence factors, long-term antibiotic treatments, and polymicrobial infections.一种慢性肺部感染小鼠模型,可用于研究晚期毒力因子、长期抗生素治疗和混合微生物感染。
bioRxiv. 2024 Sep 18:2024.09.17.613469. doi: 10.1101/2024.09.17.613469.
3
Impact of Toll-Like Receptor 2 and 9 Gene Polymorphisms on COVID-19: Susceptibility, Severity, and Thrombosis.
Toll样受体2和9基因多态性对COVID-19的影响:易感性、严重程度和血栓形成
J Inflamm Res. 2023 Feb 17;16:665-675. doi: 10.2147/JIR.S394927. eCollection 2023.
4
Toll-like receptor (TLR2, TLR4) polymorphisms and their influence on the incidence of urinary tract infections in children with and without urinary tract malformation.Toll样受体(TLR2、TLR4)多态性及其对有无泌尿系统畸形儿童尿路感染发生率的影响。
Cent Eur J Immunol. 2022;47(3):260-266. doi: 10.5114/ceji.2022.119625. Epub 2022 Sep 21.
5
Investigation of TLR2 and TLR4 Polymorphisms and Sepsis Susceptibility: Computational and Experimental Approaches.TLR2 和 TLR4 多态性与脓毒症易感性的研究:计算和实验方法。
Int J Mol Sci. 2022 Sep 19;23(18):10982. doi: 10.3390/ijms231810982.
6
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework.调节2019冠状病毒病的因素:基于不良结局途径框架的机制理解
J Clin Med. 2022 Jul 31;11(15):4464. doi: 10.3390/jcm11154464.
7
TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target.Toll样受体9(TLR9)与2019冠状病毒病(COVID-19):一个多层面治疗靶点的多学科理论
Front Pharmacol. 2021 Jan 15;11:601685. doi: 10.3389/fphar.2020.601685. eCollection 2020.
8
A mouse model of human TLR4 D299G/T399I SNPs reveals mechanisms of altered LPS and pathogen responses.人类 TLR4 D299G/T399I 单核苷酸多态性的小鼠模型揭示了 LPS 和病原体反应改变的机制。
J Exp Med. 2021 Feb 1;218(2). doi: 10.1084/jem.20200675.
9
Host Innate Immune Responses to Infection.宿主对感染的固有免疫反应。
Front Cell Infect Microbiol. 2020 Sep 14;10:486. doi: 10.3389/fcimb.2020.00486. eCollection 2020.